Merck ends study of cholesterol drug
Wednesday, May 21, 2008 - 18:14
in Health & Medicine
(AP) -- Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to allow sales of the drug.